Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (6): 1196-1201. doi: 10.19723/j.issn.1671-167X.2022.06.023

Previous Articles     Next Articles

Pulpotomy of human primary molars with novel bioceramic material

Shuang WANG,Chu-fang PENG,He LIU*()   

  1. Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Research Center of Engineering and Technology for Computerized Dentistry & NMPA Key Laboratory for Dental Materials, Beijing 100081, China
  • Received:2020-03-12 Online:2022-12-18 Published:2022-12-19
  • Contact: He LIU E-mail:heliu69@126.com
  • Supported by:
    the New Clinical Technology and New Therapy Project of Peking University Hospital of Stomatology(PKUSSNCT-18B10)

RICH HTML

 19   

PDF (PC)

151

Abstract:

Objective: To evaluate the efficacy of iRoot BP Plus, a novel bioceramic material, and mineral trioxide aggregate (MTA) by comparing the clinical and radiographic results of pulpotomy in human primary molars, and to find out the influence factor. Methods: Children who had at least one primary molar diagnosed as pulpitis, and received pulpotomy in the Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology from January, 2017 to December, 2018 were searched by the selection criteria in the Electronic Medical Record Database of Peking University School and Hospital of Stomatology. The molars with the pulp capping agents were iRoot BP Plus or MTA were included, and the molars with other pulp capping agents were excluded. Molars using iRoot BP Plus were selected into the experimental group (iRoot BP Plus group). Molars using MTA were selected into the control group (MTA group) using propensity score matching model (1 ∶ 1), considering the gender, age, tooth position, the title of clinician, pulp status, restoration and length of follow-up as the potential influence factor. Basic information, the relevant medical records including symptoms, clinical and radiographic examination before and after operation, intraoperative information and follow up examination records were collected. The success rates were compared and the influence factors were analyzed respectively. Results: The study included 132 children, 178 molars (89 molars from each group) and the mean follow-up time was (462±99) days by December, 2019. In the iRoot BP Plus group, 9 molars failed whilst 6 molars failed in MTA group. The success rate was 89.9% and 93.3%, respectively, showing no significant difference between the two groups. Through Cox proportional risk model analysis, the success rate of iRoot BP Plus was significantly lower when the pulp status was poor, while other factors including age, tooth position, title of clinician and restoration were not found to be associated with the clinical outcome. Conclusion: Pulpotomy of human primary molars with iRoot BP Plus has the same effectiveness with MTA. The pulp status is the main factor that influences the outcome of iRoot BP Plus. Further studies with larger sample sizes and longer follow-up terms are needed.

Key words: Pulpotomy, Novel bioceramic material, Pulpitis

CLC Number: 

  • R788.2

Table 1

Tooth information of iRoot BP Plus group and MTA group before and after PSM (in tooth units)"

ItemsBefore PSMPAfter PSMP
iRoot BP Plus
(n=89)		 MTA
(n=1 434)		 iRoot BP Plus
(n=89)		 MTA
(n=89)
Gender, n(%) 0.750 1.000
  Male 45(51.6) 750(52.3) 45(51.6) 45(51.6)
  Female 44(49.4) 684(47.7) 44(49.4) 44(49.4)
Age/years 5.11±0.98 5.71±1.81 0.008 5.11±0.98 5.21±1.04 0.518
Tooth position, n(%) 0.442 0.812
  Maxillary first primary molar 22(24.7) 387(27.0) 22(24.7) 24(27.0)
  Maxillary second primary molar 14(15.7) 336(23.4) 14(15.7) 18(20.2)
  Mandibular first primary molar 23(25.8) 315(22.0) 23(25.8) 20(22.5)
  Mandibular first primary molar 30(33.7) 396(27.6) 30(33.7) 27(30.3)
Title of clinician, n(%) 0.000 0.524
  Resident doctor & intern 26(29.2) 734(51.2) 26(29.2) 28(31.5)
  Attending doctor 60(67.4) 466(32.5) 60(67.4) 55(61.8)
  Professor 3(3.4) 234(16.3) 3(3.4) 6(6.7)
Pulp status, n(%) 0.035 0.593
  Good 67(75.3) 1180(82.3) 67(75.3) 70(78.7)
  Poor 22(24.7) 254(17.7) 22(24.7) 19(21.3)
Restoration, n(%) 0.000 0.225
  Composite resin 82(92.1) 1017(70.9) 82(92.1) 77(86.5)
  Stainless steel crown 7(7.9) 417(29.1) 7(7.9) 12(13.5)
Length of follow-up/d, $\bar x \pm s$ 454±93 498±268 0.019 454±93 470±104 0.299

Figure 1

Survival curve of iRoot BP Plus group and MTA group MTA, mineral trioxide aggregate."

Table 2

Cox proportional risk regression analysis of iRoot BP Plus group and MTA group"

Influence factorsiRoot BP Plus MTA
Exp(B)95%CI for Exp(B)P Exp(B)95%CI for Exp(B)P
Lower UpperLower Upper
Pulp status 0.081 0.016 0.410 0.002 1.005 0.105 9.642 0.996
Age 0.643 0.251 1.645 0.357 1.349 1.002 3.229 0.439
Title of clinician 0.993 0.369
Tooth position 0.547 0.982
Restoration 20 822 0.000 1.276×108 0.973 0.999 0.085 11.691 1.000
1 Fuks AB . Current concepts in vital primary pulp therapy[J]. Eur J Paediatr Dent, 2002, 3 (3): 115- 120.
2 Subramaniam P , Konde S , Mathew S , et al. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study[J]. J Clin Pediatr Dent, 2009, 33 (4): 311- 314.
doi: 10.17796/jcpd.33.4.r83r38423x58h38w
3 Tani-Ishii N , Hamada N , Watanabe K , et al. Expression of bone extracellular matrix proteins on osteoblast cells in the presence of mineral trioxide[J]. J Endod, 2007, 33 (7): 836- 839.
doi: 10.1016/j.joen.2007.02.003
4 Moghaddame-Jafari S , Mantellini MG , Botero TM , et al. Effect of ProRoot MTA on pulp cell apoptosis and proliferation in vitro[J]. J Endod, 2005, 31 (5): 387- 391.
doi: 10.1097/01.don.0000145423.89539.d7
5 Alsubait S , Al-Haidar S , Al-Sharyan N . A comparison of the discoloration potential for endosequence bioceramic root repair material fast set putty and ProRoot MTA in human teeth: An in vitro study[J]. J Esthet Restor Dent, 2017, 29 (1): 59- 67.
doi: 10.1111/jerd.12264
6 Moinzadeh AT , Portoles CA , Wismayer PS , et al. Bioactivity potential of endo sequence BCRRM putty[J]. J Endod, 2016, 42 (4): 615- 621.
doi: 10.1016/j.joen.2015.12.004
7 Rifaey HS , Villa M , Zhu Q , et al. Comparison of the osteogenic potential of mineral trioxide aggregate and endosequence root repair material in a 3-dimensional culture system[J]. J Endod, 2016, 42 (5): 760- 765.
doi: 10.1016/j.joen.2016.02.001
8 Shokouhinejad N , Nekoofar MH , Razmi H , et al. Bioactivity of endosequence root repair material and Bioaggregate[J]. Int Endod J, 2012, 45 (12): 1127- 1134.
doi: 10.1111/j.1365-2591.2012.02083.x
9 Carvalho CN . Effect of root repair materials and bioactive glasses on microhardness of dentin[J]. Iran Endod J, 2018, 13 (3): 337- 341.
10 Caliendo M , Kopeinig S . Some practical guidance for the implementation of propensity score matching[J]. J Econ Surv, 2005, 22 (1): 31- 72.
11 Taha NA , Safadi RA , Alwedaie MS . Biocompatibility evaluation of EndoSequence root repair paste in the connective tissue of rats[J]. J Endod, 2016, 42 (10): 1523- 1528.
doi: 10.1016/j.joen.2016.07.017
12 Zhang J , Zhu LX , Cheng X , et al. Promotion of dental pulp cell migration and pulp repair by a bioceramic putty involving FGFR-mediated signaling pathways[J]. J Dent Res, 2015, 94 (6): 853- 862.
doi: 10.1177/0022034515572020
13 Zhang S , Yang X , Fan M . BioAggregate and iRoot BP Plus optimize the proliferation and mineralization ability of human dental pulp cells[J]. Int Endod J, 2013, 46 (10): 923- 929.
doi: 10.1111/iej.12082
14 Öncel TZ , Torun D , Demirkaya K , et al. Effects of iRoot BP and white mineral trioxide aggregate on cell viability and the expression of genes associated with mineralization[J]. Int Endod J, 2015, 48 (10): 986- 993.
doi: 10.1111/iej.12393
15 Liu S , Wang S , Dong Y . Evaluation of a bioceramic as a pulp capping agent in vitro and in vivo[J]. J Endod, 2015, 41 (5): 652- 657.
doi: 10.1016/j.joen.2014.12.009
16 雷玥, 杨颖婷, 战园. 生物陶瓷材料在乳牙牙髓切断术中的应用[J]. 北京大学学报(医学版), 2019, 51 (1): 70- 74.
17 Matthias Z , Nicolas D , Yunling D , et al. Cytokine gene expression: Part of host defence in pulpitis[J]. Cytokine, 2003, 22 (3): 84- 88.
18 Wang Z , Ma J , Shen Y , et al. Acidic pH weakens the microhardness and microstructure of three tricalcium silicate materials[J]. Int Endod J, 2015, 48 (4): 323- 332.
doi: 10.1111/iej.12318
19 Hansen SW , Marshall JG , Sedgley CM . Comparison of intracanal EndoSequence root repair material and ProRoot MTA to induce pH changes in simulated root resorption defects over 4 weeks in matched pairs of human teeth[J]. J Endod, 2011, 37 (4): 502- 506.
doi: 10.1016/j.joen.2011.01.010
20 Asgary S , Eghbal MJ . Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: A multi-center randomized controlled trial[J]. Acta Odontol Scand, 2013, 71 (1): 130- 136.
doi: 10.3109/00016357.2011.654251
21 Holan G , Fuks AB , Ketlz N . Success rate of formocresol pulpotomy in primary molars restored with stainless steel crown vs. amalga[J]. Pediatr Dent, 2002, 24 (3): 212- 216.
22 Soxman JA . Stainless steel crown and pulpotomy: procedure and technique for primary molars[J]. Gen Dent, 2000, 48 (3): 294- 297.
23 Dhar V , Marghalani AA , Crystal YO . Use of vital pulp therapies in primary teeth with deep caries lesions[J]. Pediatr Dent, 2017, 39 (5): 146- 159.
24 Ibricevic H , Al-Jame Q . Ferric sulfate as pulpotomy agent in primary teeth: Twenty month clinical follow-up[J]. J Clin Pediatr Dent, 2000, 24 (4): 269- 272.
[1] Wei YONG,Kun QIAN,Wen-hao ZHU,Xiao-yi ZHAO,Chang LIU,Jie PAN. X-ray evaluation of pulp calcification in adult permanent teeth after pulpotomy [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 88-93.
[2] QIAN Kun,PAN Jie,ZHU Wen-hao,ZHAO Xiao-yi,LIU Chang,YONG Wei. Evaluation of bioceramic putty repairmen iRoot and mineral trioxide aggregate in mature permanent teeth pulpotomy [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 113-118.
[3] Ying-yi CHEN,Zi-qi HU,Tian-qian HUI,He LIU. Enhancer of zeste homolog 2 affects dental pulp inflammation by regulating macrophage chemotaxis [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 18-23.
[4] Yue LEI,Ying-ting YANG,Yuan ZHAN. Evaluation of bioceramic putty repairment in primary molars pulpotomy [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 70-74.
[5] DOU Gui-li， WU Nan, ZHAO Shuang-yun, XIA Bin. Two-year outcomes of pulpotomy in primary molars using mineral trioxide aggregate: a retrospective study [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 170-175.
[6] LING Long, ZHAO Yu-ming, GE Li-hong. Impact of different degree pulpitis on cell proliferation and osteoblastic differentiation of dental pulp stem cell in Beagle immature premolars [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 878-883.
[7] GUO Yi-dan, ZHANG Sun. Preliminary research of Er:YAG laser used for pulpotomy of Beagle dogs [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 714-719.
[8] CHEN Hong-tao, WANG Wen-ying, WANG Jin, LIANG Ya-ping, WANG Xiao-ting, HOU Guang-min, JI Ai-ping. Risk assessment of different grades of hypertension during the treatment of patients with acute pulpitis [J]. Journal of Peking University(Health Sciences), 2016, 48(1): 89-93.
[9] YU Tao, JIANG Ting, WEI Qing-mei, LI Yi-fen, David L. Kaplan. Wound healing effects of silk fibroin-bone morphogenetic protein-2 scaffolds on inflammatory pulp in rats [J]. Journal of Peking University(Health Sciences), 2015, 47(5): 814-819.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 434 -436 .
[2] . [J]. Journal of Peking University(Health Sciences), 2001, 33(3): 288 -289 .
[3] . [J]. Journal of Peking University(Health Sciences), 2002, 34(2): 97 -98 .
[4] . [J]. Journal of Peking University(Health Sciences), 2002, 34(2): 112 -116 .
[5] . [J]. Journal of Peking University(Health Sciences), 2011, 43(1): 29 -33 .
[6] . [J]. Journal of Peking University(Health Sciences), 2011, 43(2): 179 -182 .
[7] . [J]. Journal of Peking University(Health Sciences), 2001, 33(1): 50 -53 .
[8] . [J]. Journal of Peking University(Health Sciences), 2002, 34(2): 140 -143 .
[9] . [J]. Journal of Peking University(Health Sciences), 2010, 42(4): 476 -479 .
[10] . [J]. Journal of Peking University(Health Sciences), 2008, 40(2): 208 -210 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd